Can You Sell a Patent to a Company? Yes, Here Is How

Can you sell a patent to a company? Yes. Legally it is one of the simplest transactions in intellectual property: one signed document moves the right from you to the buyer.

Commercially it is a different story. Most inventors who try it write to the biggest names in their industry, hear nothing back, and conclude the patent is worthless. Usually the patent is not the problem. The approach is.

This guide covers both halves: what the law requires, why companies say no by reflex, who inside a company actually buys, and how a direct sale runs from first contact to a recorded assignment. It is general information, not legal advice; your patent attorney should review any deal before you sign.

The short answer: yes, and the law makes it simple

In the United States, patents have the attributes of personal property. Patents and applications are assignable by an instrument in writing, and the owner can also grant an exclusive right for the whole country or a specified part of it.

Three consequences follow for a seller:

• Any company can be the buyer. There is no licensing regime, no approval from the patent office, no requirement that the buyer is in your field.
• Pending applications can be sold too. The statute covers applications as well as granted patents, although a buyer prices a pending application very differently. More on that when we look at how to sell a pending application.
• You can sell less than everything. An exclusive right limited to a territory, or a licence instead of a sale, are both options if an outright assignment is not what the company wants.

So the legal question has a clean answer. The real question is whether a company will buy yours, and that is where most attempts go wrong.

Why most direct pitches to companies stall

Unsolicited idea policies

Many large companies publish a policy on outside submissions, and reading one explains more than any forum thread. Axon's policy regarding unsolicited ideas is typical. Anything submitted before a formal agreement is treated as unsolicited. It comes with no confidentiality. The company says most unsolicited ideas are not patentable and its engineers have very likely considered them already. And it describes handling outsiders' ideas as an expense with only a small chance of return.

That last line is the corporate view in one sentence. Your email does not arrive as an opportunity. It arrives as a cost and a risk.

The litigation fear

The European Patent Office's inventor handbook is blunt about why: very few major companies genuinely welcome external ideas. They receive many unsolicited submissions, rarely treat them as a priority, and fear inventors who later accuse them of IP theft. The simplest remedy, as the EPO puts it, is not to deal with inventors at all.

Think about it from the company's side. If its R&D team is already working on something similar and it reads your submission, it has just created evidence for a lawsuit it may not deserve. Refusing to look is the cheapest defence.

Wrong door, wrong person

Even when a company would buy, inventors knock on the wrong door. One patent attorney argues that starting with legal or licensing departments is a strategic mistake, and that engineering and product leaders are the people who value a technology. A letter that opens with a patent number and a claim chart reads like a legal threat. A letter that opens with a problem the product team has reads like help.

What changes when you hold a patent, not an idea

A bare idea has almost no legal protection in the United States. A company can hear the pitch, build the product and owe you nothing. That is why "can I sell my idea to a company" and "can I sell my patent to a company" are really two different questions, and why we answer selling an idea without a patent separately.

A patent changes the conversation in two ways. First, the company is no longer being asked to trust you; it is being asked to evaluate a defined asset with published claims. Second, it answers the objection companies raise themselves. Axon states it generally does not invest in technology that cannot be protected by patent. A granted patent, or a well drafted pending application, is exactly the protection a buyer needs before committing budget.

Be precise about which one you hold. A pending application is an option on a future right, and the claims may narrow or be refused in examination. A granted patent is an enforceable right today. Both are sellable. They are not priced the same, and a buyer will notice immediately if you blur the two.

Who inside a company actually buys patents

Companies that buy patents rarely do it by reading their inbox. Corporate IP teams managing large portfolios buy through processes, trusted sources and brokers they already know. That is a large part of how hard it is to sell a patent as an individual.

Relationships matter more than cold outreach. MIT's technology licensing office tells its inventors that over 70% of all licenses are executed with commercial entities known by the inventor. That figure is about university licensing, not individual sales, but the lesson carries: the company that knows you, or knows someone who vouches for you, is the company that reads your material.

Inside a buying company there are usually three people to win over:

1. The technical champion, an engineering or product leader who sees the fit.
2. The IP function, which checks validity, scope and whether the claims read on real products.
3. The budget owner, who has to justify the spend against building around the patent or doing nothing.

A direct pitch that only reaches one of them rarely closes.

How a direct sale to a company works, step by step

Pick targets that practise the claims

Start with companies whose products or roadmap sit inside your claims, or that need your claims to close a gap in their own portfolio. The same EPO handbook suggests that smaller companies often move faster and have decision makers who are easier to reach. A mid-sized company with one product line that depends on your technology is a far better target than a household name with a submissions portal.

Lead with the problem, not the patent

Your first message should describe the problem the invention solves and the evidence that it matters commercially, in a few paragraphs. Mention that the technology is patented or patent pending, without claim charts or accusations. Do not send confidential material the company has not agreed to protect: if your application is not yet filed, file first.

Diligence, price and the assignment

If the company engages, expect questions about validity, prior art, ownership (every inventor and any employer must be in the chain of title), and remaining term. Before you name a number, value the patent on a method you can defend; buyers anchor low when the seller cannot explain the figure.

The deal itself is documented in a patent assignment: identification of the patent or application, the price and payment terms, warranties on ownership, and what happens to any existing licences. Formalities vary by country, so check whether the assignment needs a notary where the right is registered.

Record it within three months

This is the step sellers and small buyers forget. Under US law, the same section of the statute makes an assignment void against a later purchaser who paid value without notice, unless it is recorded at the Patent and Trademark Office within three months of its date or before that later purchase. A serious buyer will insist on recording. If you are the buyer's counterparty, cooperate quickly; delays here raise doubts about the whole deal.

Patent rights are territorial. A German patent or a European validation is assigned and registered in its own system, so a family with members in several countries means several recordals.

Selling direct vs using a broker

Direct sales work best when you already know the buyer, the fit is obvious, and the company has a reason to move now. When none of that is true, the odds are poor, and they are not great even with professional help: brokered patent packages listed from 2016 to 2020 sold 21% of the time.

A broker earns a fee by solving the problems described above: finding the right people inside the right companies, packaging the asset so an IP team can assess it quickly, and running a controlled process instead of a stream of cold emails. If you are weighing the two routes, read what a patent broker does and the best way to sell a patent before committing.

At EX-IX we run patent sales the way a banker runs an M&A mandate: valuation, buyer targeting, controlled outreach and deal support to close. Our brokerage is paid on completion by the seller, with a minimum fee of EUR 5,000 per completed transaction, so there is no fee if there is no sale. Before an asset reaches a buyer it goes through a digital twin validation gate that reconstructs the claims and checks detectability, because an IP team that trusts the package on day one moves faster. None of that guarantees a buyer or a price; no honest broker can.

One distinction worth keeping clear: selling the patent is not the same as selling products that use it. If what you really want is to bring a product to market, see our guide on selling a patented product.

FAQ

Will a company sign an NDA before I pitch my patent?

Often not for unsolicited submissions. Axon's policy, for example, states that unsolicited ideas come without any agreement to keep them confidential. Assume anything you send may not be protected, and make sure your application is filed before you disclose details.

Do I need a lawyer to sell a patent to a company?

The law only requires a written instrument. In practice, have a patent attorney draft or review the assignment, because warranties, chain of title and recording mistakes are expensive to fix after closing.

Should I approach big companies or small ones first?

Usually smaller and mid-sized companies. They receive fewer submissions, decide faster, and are more likely to depend on a single technology that your patent covers.

Can I sell a patent to a company in another country?

Yes. The buyer can be anywhere, but each national right is assigned and registered in its own country. A US patent is recorded at the USPTO; a German patent is registered in Germany.